Portage Biotech Navigates Strategic Changes Amid Loss Reduction
PremiumCompany AnnouncementsPortage Biotech Navigates Strategic Changes Amid Loss Reduction
1M ago
Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update
Premium
Press Releases
Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update
1M ago
Portage Biotech reports 2024 EPS ($3.89) vs. ($6.49) last year
Premium
The Fly
Portage Biotech reports 2024 EPS ($3.89) vs. ($6.49) last year
1M ago
Portage Biotech Explores Strategic Alternatives
PremiumCompany AnnouncementsPortage Biotech Explores Strategic Alternatives
5M ago
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
Premium
Press Releases
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
5M ago
Portage to expand review of alternatives, pauses ADPORT-601 trial enrollment
Premium
The Fly
Portage to expand review of alternatives, pauses ADPORT-601 trial enrollment
5M ago
H.C. Wainwright downgrades Portage Biotech on financing overhang
PremiumThe FlyH.C. Wainwright downgrades Portage Biotech on financing overhang
9M ago
Portage Biotech downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Portage Biotech downgraded to Neutral from Buy at H.C. Wainwright
9M ago
Portage Biotech to evaluate range of strategic options
Premium
The Fly
Portage Biotech to evaluate range of strategic options
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100